The observation of increased t‐tau levels in patients with AG compared to GG MAPT rs1467967 genotype was confirmed when combining AD and MCI patients, and healthy controls (p = 0.004; Figure 1b) and in AD and MCI patients (p = 0.005; Figure 1c). This evidence concerns the gene MAPT and Alzheimer disease.